Celecoxib Capsule
Product Images NDC 11788-113

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Celecoxib (NDC 11788-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aiping Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-100s-label.jpg (100mg 100s Label)

The text contains information about capsules containing 100 mg of celecoxib, stored at room temperature between 15°C to 30°C (69°F to 86°F). It also mentions to dispense in child-resistant containers and has Rx Only status. The capsules are from an FDA-approved pharmaceutical company.*

FDA Label Image

100mg-500s-label.jpg (100mg 500s Label)

This is a description for a medication called Celecoxib in capsule form with 100 mg strength. The pharmacist should dispense a Medication Guide with each capsule to the patients. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The prescribing information should be consulted for dosage and usage instructions. The capsules should be dispensed in child-resistant containers. The medication is manufactured by AiPing Pharmaceutical in Hauppauge, NY. Further details can be found on their website.*

FDA Label Image

200mg-100s-label.jpg (200mg 100s Label)

This is a description for the medication "Celecoxib Capsules 200 mg". Each capsule contains 200 mg of celecoxib and should be dispensed in light-resistant containers. It is manufactured for AiPing Pharmacetical, Inc. and the dosage and usage instructions can be found in the accompanying prescribing information. The medication should be stored at room temperature with excursions permitted between 15°C to 30°C. For more information, a medication guide can be printed from the website: aipingpharmaceutical.com/products.*

FDA Label Image

200mg-500s-label.jpg (200mg 500s Label)

This is a description of Celecoxib capsules containing 200 mg of the active ingredient. The medication is dispensed in child-resistant containers and should be stored at room temperature. The text provides information for pharmacists to dispense the capsules and refers to prescribing information for dosage and use instructions. The manufacturer is AiPing Pharmaceutical, based in Hauppauge, NY. The prescription is for 500 capsules. The text also includes a reference to a medication guide available online.*

FDA Label Image

400mg-60s-label.jpg (400mg 60s Label)

Each capsule contains 400 mg of celecoxip. It is recommended to store them at room temperature between 20°C to 25°C (68°F to 77°F) in child-resistant containers. The dosage and use should be handled according to USP Controlled Room Temperature guidelines. These capsules are manufactured by AlPing Pharmaceutical, Inc. For more information, visit their website: https://alpingpharmaceutical.com/products.*

FDA Label Image

50mg-60s-label.jpg (50mg 60s Label)

The text provides information about a medication in capsule form, specifically Celecoxib Capsules. It should be stored at room temperature between 20°C to 25°C. Excursions are permitted between 15°C to 30°C. The capsules should be dispensed according to USP guidelines and should be kept in child-resistant containers. Instructions for use and more details can be found at the website "shippingpharmaceuticalproducts." The product's NDC number is 11788-112-60, and it contains 60 capsules. The text also shows the company name as "AiPing" and the location as Hauppauge, NY 11788, with a prescription requirement.*

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

FDA Label Image

Table3-2 (Table 3 2)

FDA Label Image

Table (Table)

This is a comparison of side effects associated with Celecoxib (400 to 800 mg daily) and Placebo. The table shows the percentage occurrence of specific side effects such as diarrhea, gastroesophageal reflux disease, nausea, vomiting, dyspnea, hypertension, and nephrolithiasis in a study with 2285 participants receiving Celecoxib and 1303 participants receiving Placebo. The results highlight the differences in the incidence rates of these adverse events between the two groups.*

FDA Label Image

Table1 (Table1)

This is a list of adverse events occurring in 2% of patients who were taking Celecoxib in pre-marketing controlled arthritis trials. The table displays percentages of different side effects such as gastrointestinal issues, body pain, nervous system reactions, psychiatric symptoms, respiratory problems, and skin reactions among others. Each percentage is compared between patients taking Celecoxib, placebo, Naproxen, Diclofenac, and 1-Butyl-10-gBenzoguanidine (1BU). The text provides an insight into the occurrence of adverse events in patients using these medications.*

FDA Label Image

Table2 (Table2)

This is a detailed table outlining adverse events occurring in over 5% of Juvenile Rheumatoid Arthritis patients across different treatment groups. It provides valuable information on the frequency of various adverse events such as eye disorders, gastrointestinal issues, infections, musculoskeletal problems, and respiratory symptoms among others. Additionally, it includes data on laboratory test abnormalities observed in the patients.*

FDA Label Image

Image Description (Table3 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.